How To Prevent Pitfalls When Pursuing Patent Protection

When B. Stanley Pons and Martin Fleischmann announced that they had achieved cold fusion last March, the scientific community understandably clamored for details. But information was not forthcoming, at least in part because patents were rapidly being filed on the work. Even though scientific secrecy can be maddening in cases such as this, patents are very much a part of science. In today's environment, when even organisms and equations are being patented, filing a patent application can be comp

Written byRicki Lewis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Even though scientific secrecy can be maddening in cases such as this, patents are very much a part of science. In today's environment, when even organisms and equations are being patented, filing a patent application can be complicated—especially the first time around. Here, for Scientists faced with the formidable and confusing process of applying for a patent, are some frequently asked questions-along with the corresponding answers.

In recent years, the scope of what can be patented has broadened appreciably. Since 1982, for example, algorithms have been patentable, reversing the long-standing consideration of these mathematical expressions as scientific truths, therefore exempt from patent protection.

A molecule, cell, or organism is patentable if it does not exist in nature. This might be a change as minor as an amino acid substitution in a protein, or as inventive as artificial seeds. Merely determining the sequence of a protein or gene isn't patentable, unless ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies